Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease

T Zetzsche, D Rujescu, J Hardy… - Expert review of …, 2010 - Taylor & Francis
Despite important recent advances, a full understanding of the (genetic) etiology of
Alzheimer's disease (AD) is still a long way off. Large collaborative efforts are ongoing, as …

The molecular and neuropathological consequences of genetic risk for Alzheimer's dementia

S Tasaki, C Gaiteri, S Mostafavi, PL De Jager… - Frontiers in …, 2018 - frontiersin.org
Alzheimer's dementia commonly impacts the health of older adults and lacks any
preventative therapy. While Alzheimer's dementia risk has a substantial genetic component …

[PDF][PDF] Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE

L Bertram, C Lange, K Mullin, M Parkinson… - The American Journal of …, 2008 - cell.com
Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder. To date four
genes have been established to either cause early-onset autosomal-dominant AD (APP …

Alzheimer's disease: a general introduction and pathomechanism

VH Finder - Journal of Alzheimer's disease, 2010 - content.iospress.com
Alzheimer's disease (AD) is the most common form of dementia, which affects more than 35
million people worldwide with increasing tendency. Satisfying therapies and prevention are …

A brief synopsis on the genetics of Alzheimer's disease

MI Kamboh - Current genetic medicine reports, 2018 - Springer
Alzheimer's disease (AD) is the most common form of dementia, accounting for 60–80% of
all dementia cases [1]. Due to variation in age at onset (AAO), AD is classified as either early …

The genetics and neuropathology of Alzheimer's disease

GD Schellenberg, TJ Montine - Acta neuropathologica, 2012 - Springer
Here we review the genetic causes and risks for Alzheimer's disease (AD). Early work
identified mutations in three genes that cause AD: APP, PSEN1 and PSEN2. Although …

APP, PSEN1, and PSEN2 Variants in Alzheimer's Disease: Systematic Re-evaluation According to ACMG Guidelines

X Xiao, H Liu, X Liu, W Zhang, S Zhang… - Frontiers in aging …, 2021 - frontiersin.org
The strategies of classifying APP, PSEN1, and PSEN2 variants varied substantially in the
previous studies. We aimed to re-evaluate these variants systematically according to the …

New insights into the molecular bases of familial Alzheimer's disease

V D'Argenio, D Sarnataro - Journal of Personalized Medicine, 2020 - mdpi.com
Like several neurodegenerative disorders, such as Prion and Parkinson diseases,
Alzheimer's disease (AD) is characterized by spreading mechanism of aggregated proteins …

Genetic markers of Alzheimer's disease

M Nikolac Perkovic, N Pivac - Frontiers in Psychiatry: Artificial Intelligence …, 2019 - Springer
Alzheimer's disease is a complex and heterogeneous, severe neurodegenerative disorder
and the predominant form of dementia, characterized by cognitive disturbances, behavioral …

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

I De Rojas, S Moreno-Grau, N Tesi… - Nature …, 2021 - nature.com
Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and
together with polygenetic risk stratification can contribute towards planning of feasible and …